Top Purchase Related
Home
>
Node
>
Subnode

Efficacy of treatment of breast cancer

Levshin, V.F.

Voprosy Onkologii 17(8): 108-118

1971

ISSN/ISBN: 0507-3758
PMID: 4943960
Document Number: 38190

Document emailed within 1 workday
Secure & encrypted payments

Levshin, V.F. 1971: Efficacy of treatment of breast cancer Voprosy Onkologii 17(8): 108-118
Ohtake, T.; Yasuda, M.; Watanabe, K.; Ito, T.; Ito, J.; Miyamoto, K.; Yoshida, S.; Abe, N.; Ishigame, T.; Ishii, M.; Kimijima, I.; Takenoshita, S. 2009: Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1459-1463
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107
Chan, M.Yi.; Ip, W.Yim.; Choi, K.Chow. 2016: The effect of a self-efficacy-based educational programme on maternal breast feeding self-efficacy, breast feeding duration and exclusive breast feeding rates: A longitudinal study Midwifery 36: 92-98
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Wahner-Roedler, D.L.; Petersen, I.A. 2004: Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma Drugs of Today 40(10): 865-879
Rintasyöpäryhmä ry, S. 1997: Recommended treatment guideline for breast cancer. Finnish Breast Cancer Group Duodecim; Laaketieteellinen Aikakauskirja 113(22): 2341-2348
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Rosselli Del Turco, M.; Palli, D.; Cariddi, A.; Ciatto, S.; Pacini, P.; Distante, V. 1994: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up JAMA 271(20): 1593-1597
Tagashira, H.; Matsuhisa, T.; Oze, I.; Kiyoto, S.; Takahashi, M.; Hara, F.; Takabatake, D.; Takashima, S.; Aogi, K.; Osumi, S.; Eguchi, H. 2011: Efficacy and safety of aprepitant in patients with breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(8): 1307-1311
Axelsson, C.K.; Andersen, J.A.; Andersen, K.W.; Blichert-Toft, M.; Dombernowsky, P.; Hansen, M.; Krag, C.; Mouridsen, H.T.; Overgaard, M.; Rasmussen, B.B. 1991: Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group) Ugeskrift for Laeger 153(33): 2276-2279
Bonadonna, G.; Rossi, A.; Valagussa, P.; Veronesi, U. 1978: Actual data on efficacy of surgical adjuvant chemotherapy with CMF in breast cancer Archiv für Geschwulstforschung 48(7): 659
Halden, A.; Walter, R.M.; Gordan, G.S. 1970: Antitumor efficacy and toxicity of methyltrienolone (NSC-92858) in advanced breast cancer Cancer ChemoTherapy Reports 54(6): 453-455
Yamamura, J.; Kamigaki, S.; Hamakawa, T.; Hoshino, H.; Nakata, K.; Yamamoto, T.; Ikeda, N.; Kawase, T.; Tsujie, M.; Kimura, Y.; Ozato, H. 2015: Efficacy and Safety of Pertuzumab for HER2-Positive Metastatic Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(6): 713-717
Damkier, A.; Paludan-Müller, C.; Knoop, A.Søegaard. 2007: Use of complementary and alternative medicine (CAM) in breast cancer patients. Efficacy and interactions Ugeskrift for Laeger 169(37): 3111-3114
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Yaremchuk, A.Y.; Zotov, A.S.; Cheshuk, V.Y.; Anikusko, N.F.; Zakhartseva, L.M.; Dyatel, M.V.; Kravchenko, A.V.; Lobanova, O.Y.; Sidorchuk, O.I. 2003: An assessment of clinical efficacy of calcium nadroparin administration during surgery for breast cancer Voprosy Onkologii (St Petersburg) 49(2): 205-208
Labriola, D.; Pratt, K.; Bufi, P. 2009: 'Natural' hormone replacement and breast cancer risk: evidence for safety and efficacy Oncology 23(7): 639-641
1974: Assessment of response to treatment in advanced breast cancer. British Breast Group Lancet 2(7871): 38-39